knowledge -WSS

knowledge

author：fashion 2025-09-29 20:51:44 - browse：5937

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

An oral version of semaglutide, the drug marketed as Ozempic and Wegovy, led to dramatic weight loss in a trial enrolling people with obesity, manufacturer Novo Nordisk said Monday, data that could bolster what is already a blockbuster medicine.

In the study, which enrolled nearly 700 adults classified as having overweight or obesity, patients treated with a daily semaglutide tablet lost 15.1% of their body weight over the course of 17 months, while those on placebo lost 2.4%, Novo Nordisk said. The result is comparable to weekly injections of Wegovy, which in an earlier study led to 14.9% weight loss over the same period of time. In both studies, the most common side effects were gastrointestinal distress, with the majority of cases graded mild or moderate, the company said.

Novo Nordisk said it plans to submit oral semaglutide for U.S. and E.U. approvals later this year. A lower-dose version of the drug is already approved as a treatment for type 2 diabetes under the brand name Rybelsus.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： FDA drug safety: Singulair case shows systemic surveillance flaws

focus

WSS

Vertigo drug brings hope for rare neuron disorder, Niemann

Woodcock on FDA’s accelerated approval and her next chapter

Security flaws in third

A $475,000 price tag for a new cancer drug: crazy or meh?

AstraZeneca lung cancer study comes in below expectations

Fatty liver disease was alleviated by Lilly’s ‘triple

entertainment

knowledge

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

STAT wants to know your pick for a great summer read or listen

Peter Hotez and the public health issue of online harassment

Fatty liver disease was alleviated by Lilly’s ‘triple

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Juul spent big to court Black leaders to promote its e

Medical leaders decry Supreme Court decision on affirmative action

Juul spent big to court Black leaders to promote its e

What does generative AI mean for health care? We asked experts

A $475,000 price tag for a new cancer drug: crazy or meh?

explore

Congressmen charge Covid hearing ‘could have been an email’

Some dementia cases could be undiagnosed liver disease

Drug cartel violence flares in western Mexico after vigilante leader's killing

New Ultima Genomics DNA sequencer can read genome for $100

Biden administration opens offers in Medicare drug price negotiations

Juul spent big to court Black leaders to promote its e

focus

explore

focus

explore